MedPath

Comparison of High Versus Low Bicarbonate Hemodialysis

Not Applicable
Completed
Conditions
End-stage Renal Disease
Metabolic Acidosis
Chronic Kidney Disease
Interventions
Other: Low Bicarbonate
Registration Number
NCT02098356
Lead Sponsor
Albert Einstein College of Medicine
Brief Summary

This study will compare hemodialysis treatment with a standard, high-bicarbonate dialysis bath versus a lower bicarbonate dialysis bath, and will compare intradialytic acid-base changes and overall control of metabolic acidosis with the 2 treatment regimens.

Detailed Description

This study will compare hemodialysis treatment with a standard, high-bicarbonate dialysis bath versus a lower bicarbonate dialysis bath, and will compare intradialytic acid-base changes and overall control of metabolic acidosis with the 2 treatment regimens. These parameters will be assessed in patients currently receiving high-bicarbonate hemodialysis as part of usual care. They will then be switched to a lower bicarbonate prescription, after which these parameters will be reassessed. The study will also examine changes in inflammatory markers, glycemic control, ketogenesis, and lipolysis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Age >18
  • Receiving chronic thrice-weekly conventional hemodialysis for at least 6 months
Exclusion Criteria
  • Use of oral alkali within the previous month
  • Hospitalization within the previous month
  • Inability to provide written informed consent
  • Plans for kidney transplant in the next 2 months
  • Planned change in phosphate binder therapy within the next month
  • Pregnancy, or planned pregnancy in the next 2 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Low bicarbonateLow BicarbonateLow bicarbonate hemodialysis - 30 mEq/L dialysate bicarbonate
Primary Outcome Measures
NameTimeMethod
Pre-dialysis serum bicarbonate5 weeks

Change in predialysis bicarbonate

Secondary Outcome Measures
NameTimeMethod
beta-hydroxybutyrate clearance5 weeks

Change in clearance between different dialysates

serum beta-hydroxybutyrate5 weeks

Change in beta-hydroxybutyrate during dialysis

serum free fatty acids5 weeks

Change during dialysis

Time to recover from dialysis5 weeks

Change between dialysates

Dialysis symptom questionnaire5 weeks

Change between dialysates

interleukin-65 weeks

Change during dialysis

Trial Locations

Locations (1)

Albert Einstein College of Medicine

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath